BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 22048624)

  • 1. Carcinomas of an unknown primary origin--diagnosis and treatment.
    Massard C; Loriot Y; Fizazi K
    Nat Rev Clin Oncol; 2011 Nov; 8(12):701-10. PubMed ID: 22048624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
    Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
    Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastases of unknown origin--principles of diagnosis and treatment].
    Petrović D; Muzikravić L; Jovanović D
    Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic Portrait.
    Huey RW; Smaglo BG; Estrella JS; Matamoros A; Overman MJ; Varadhachary GR; Raghav KPS
    Oncologist; 2021 Apr; 26(4):e650-e657. PubMed ID: 33524217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary
    Dermawan JK; Rubin BP
    Semin Diagn Pathol; 2021 Nov; 38(6):193-198. PubMed ID: 33309276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of adenocarcinoma of unknown primary: are we making progress?
    Greco FA
    J Natl Compr Canc Netw; 2008 Nov; 6(10):1061-7. PubMed ID: 19176201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
    Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
    PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of unknown primary (CUP): an update for histopathologists.
    Beauchamp K; Moran B; O'Brien T; Brennan D; Crown J; Sheahan K; Cotter MB
    Cancer Metastasis Rev; 2023 Dec; 42(4):1189-1200. PubMed ID: 37394540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.
    Amela EY; Lauridant-Philippin G; Cousin S; Ryckewaert T; Adenis A; Penel N
    Crit Rev Oncol Hematol; 2012 Nov; 84(2):213-23. PubMed ID: 22503530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of carcinoma of unknown primary in the head and neck.
    Issing WJ; Taleban B; Tauber S
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):436-43. PubMed ID: 12684829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic challenges of patients with carcinoma of unknown primary.
    Rassy E; Pavlidis N
    Expert Rev Anticancer Ther; 2020 Sep; 20(9):775-783. PubMed ID: 32779501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.
    Pentheroudakis G; Greco FA; Pavlidis N
    Cancer Treat Rev; 2009 May; 35(3):221-7. PubMed ID: 19046817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
    Greco FA
    Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of patients with cancer of an unknown primary site].
    Enokida T; Ohyama Y
    Gan To Kagaku Ryoho; 2012 May; 39(5):726-30. PubMed ID: 22584324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.
    Zaun G; Schuler M; Herrmann K; Tannapfel A
    Dtsch Arztebl Int; 2018 Mar; 115(10):157-162. PubMed ID: 29587959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unknown primary tumours.
    Hillen HF
    Postgrad Med J; 2000 Nov; 76(901):690-3. PubMed ID: 11060142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.